Okada H - Search Results

1

Leukocyte cell-derived chemotaxin 2 is an antiviral regulator acting through the proto-oncogene MET.

Shirasaki T, Yamagoe S, Shimakami T, Murai K, Imamura R, Ishii KA, Takayama H, Matsumoto Y, Tajima-Shirasaki N, Nagata N, Shimizu R, Yamanaka S, Abe A, Omura H, Kawaguchi K, Okada H, Yamashita T, Yoshikawa T, Takimoto K, Taharaguchi M, Takatsuka S, Miyazaki Y, Tamai T, Tanabe Y, Kurachi M, Yamamoto Y, Kaneko S, Matsumoto K, Takamura T, Honda M. Shirasaki T, et al. Among authors: okada h. Nat Commun. 2022 Jun 8;13(1):3176. doi: 10.1038/s41467-022-30879-3. Nat Commun. 2022. PMID: 35676290 Free PMC article.

2

Altered hepatic gene expression profiles associated with myocardial ischemia.

Ootsuji H, Honda M, Kaneko S, Usui S, Okajima M, Okada H, Sakai Y, Takamura T, Horimoto K, Takamura M. Ootsuji H, et al. Among authors: okada h. Circ Cardiovasc Genet. 2010 Feb;3(1):68-77. doi: 10.1161/CIRCGENETICS.108.795484. Epub 2009 Dec 1. Circ Cardiovasc Genet. 2010. PMID: 20160198

3

La protein required for internal ribosome entry site-directed translation is a potential therapeutic target for hepatitis C virus replication.

Shirasaki T, Honda M, Mizuno H, Shimakami T, Okada H, Sakai Y, Murakami S, Wakita T, Kaneko S. Shirasaki T, et al. Among authors: okada h. J Infect Dis. 2010 Jul 1;202(1):75-85. doi: 10.1086/653081. J Infect Dis. 2010. PMID: 20497049

4

Acyclic retinoid targets platelet-derived growth factor signaling in the prevention of hepatic fibrosis and hepatocellular carcinoma development.

Okada H, Honda M, Campbell JS, Sakai Y, Yamashita T, Takebuchi Y, Hada K, Shirasaki T, Takabatake R, Nakamura M, Sunagozaka H, Tanaka T, Fausto N, Kaneko S. Okada H, et al. Cancer Res. 2012 Sep 1;72(17):4459-71. doi: 10.1158/0008-5472.CAN-12-0028. Epub 2012 May 31. Cancer Res. 2012. PMID: 22651928

5

MicroRNA-27a regulates lipid metabolism and inhibits hepatitis C virus replication in human hepatoma cells.

Shirasaki T, Honda M, Shimakami T, Horii R, Yamashita T, Sakai Y, Sakai A, Okada H, Watanabe R, Murakami S, Yi M, Lemon SM, Kaneko S. Shirasaki T, et al. Among authors: okada h. J Virol. 2013 May;87(9):5270-86. doi: 10.1128/JVI.03022-12. Epub 2013 Feb 28. J Virol. 2013. PMID: 23449803 Free PMC article.

6

Hepatic interferon-stimulated genes are differentially regulated in the liver of chronic hepatitis C patients with different interleukin-28B genotypes.

Honda M, Shirasaki T, Shimakami T, Sakai A, Horii R, Arai K, Yamashita T, Sakai Y, Yamashita T, Okada H, Murai K, Nakamura M, Mizukoshi E, Kaneko S. Honda M, et al. Among authors: okada h. Hepatology. 2014 Mar;59(3):828-38. doi: 10.1002/hep.26788. Epub 2014 Jan 27. Hepatology. 2014. PMID: 24311440

7

Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma.

Yamashita T, Kitao A, Matsui O, Hayashi T, Nio K, Kondo M, Ohno N, Miyati T, Okada H, Yamashita T, Mizukoshi E, Honda M, Nakanuma Y, Takamura H, Ohta T, Nakamoto Y, Yamamoto M, Takayama T, Arii S, Wang X, Kaneko S. Yamashita T, et al. Among authors: okada h. Hepatology. 2014 Nov;60(5):1674-85. doi: 10.1002/hep.27093. Epub 2014 Sep 29. Hepatology. 2014. PMID: 24700365 Free PMC article. Clinical Trial.

8

Impaired interferon signaling in chronic hepatitis C patients with advanced fibrosis via the transforming growth factor beta signaling pathway.

Shirasaki T, Honda M, Shimakami T, Murai K, Shiomoto T, Okada H, Takabatake R, Tokumaru A, Sakai Y, Yamashita T, Lemon SM, Murakami S, Kaneko S. Shirasaki T, et al. Among authors: okada h. Hepatology. 2014 Nov;60(5):1519-30. doi: 10.1002/hep.27277. Epub 2014 Oct 2. Hepatology. 2014. PMID: 24962339

9

TSU-68 ameliorates hepatocellular carcinoma growth by inhibiting microenvironmental platelet-derived growth factor signaling.

Hara Y, Yamashita T, Oishi N, Nio K, Hayashi T, Nomura Y, Yoshida M, Hayashi T, Hashiba T, Asahina Y, Kondo M, Okada H, Sunagozaka H, Honda M, Kaneko S. Hara Y, et al. Among authors: okada h. Anticancer Res. 2015 Mar;35(3):1423-31. Anticancer Res. 2015. PMID: 25750293

10

Defeating EpCAM(+) liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma.

Nio K, Yamashita T, Okada H, Kondo M, Hayashi T, Hara Y, Nomura Y, Zeng SS, Yoshida M, Hayashi T, Sunagozaka H, Oishi N, Honda M, Kaneko S. Nio K, et al. Among authors: okada h. J Hepatol. 2015 Nov;63(5):1164-72. doi: 10.1016/j.jhep.2015.06.009. Epub 2015 Jun 18. J Hepatol. 2015. PMID: 26095183

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,491 results

Search Page